Most TMF operating models are built on an assumption that's quietly become false: that filing can run as background work, fixed properly later, because inspections are episodic and there's always time to clean up before one arrives. Under ICH E6(R2), that assumption was already fragile. With ICH E6(R3) now in effect in the EU/EEA as of EMA's 23 July 2025 date, three specific provisions turn it from fragile into a direct liability.
Appendix C doesn't offer a static checklist of documents to file and forget. It defines essential records as whatever documents, data, and metadata "facilitate the ongoing management of the trial" and allow trial conduct to be reconstructed after the fact.
That's a deliberately broader standard than a fixed list, and it means the question an inspector asks isn't "do these documents exist somewhere in the repository" it's whether an organization can show, from its own systems, that the records supporting each trial decision are complete, current, and governed.
Section C.2 goes further than definition into mechanics: essential records must be identifiable and version-controlled, blinding and privacy have to be actively protected as records move between stakeholders, and certain categories SOPs, validation records, master service agreements can be retained outside the TMF proper, but only if they stay readily available and governed.
That last clause matters: it removes "it's filed somewhere else" as an acceptable answer unless that somewhere else is actually accessible and managed with the same rigor.
Section 4.2.3 closes the loop by requiring that review of trial-specific data and metadata including audit trails be planned, risk-based, and documented.
An ad hoc CSV export triggered by pre-inspection anxiety doesn't satisfy that standard, because the requirement isn't just that a review happened, it's that it was planned as an ongoing activity in the first place.
Layer EU Clinical Trials Regulation and the Clinical Trials Information System on top of these three provisions, and the direction is unambiguous: EMA already expects sponsors to organize submissions, communications, and disclosure across EU/EEA trials in a consistent, traceable way. Appendix C and Section 4.2.3 simply make explicit what inspectors were, in practice, already starting to test for informally.
Most sponsors and mid-size CROs, if they're honest about their architecture, can't cleanly answer the question these three provisions are really asking. CTMS and eTMF often sit on different stacks. Site activation, monitoring, and trial finance keep moving while TMF filing lags behind. A CRO's eTMF and a sponsor's repository each tell a partial story.
Audit-trail review lives as a one-off export exercise rather than a documented, recurring activity. When an inspection is announced, the response is a war room completeness reports, CTMS listings, and ad hoc trackers pulled together and reconciled under deadline.
That scramble used to be merely stressful. In a funding environment where every week of delay carries a higher visible cost, spending 60 to 90 days on reactive clean-up before an inspection is time not spent on recruitment, dataset locks, or advancing other programs in the portfolio and it's exactly the kind of manual remediation Section 4.2.3 is designed to make insufficient on its own.
| Reactive Pre-Inspection Clean-Up | Static Completeness Dashboard | Unified CTMS↔eTMF With an Embedded Agent | |
|---|---|---|---|
| When gaps are discovered | During the pre-inspection scramble | Whenever someone checks the dashboard | As documents arrive and milestones fire |
| Audit-trail review | Ad hoc export, triggered by anxiety | Occasional, not necessarily planned | Ongoing, risk-based, and documented as it happens |
| Version control and blinding protections | Manually enforced, inconsistently | Tracked, but not necessarily proactively | Built into how records are classified and filed |
| Evidence of continuous oversight | Reconstructed under deadline | Partial reflects the last check | Reflects the live operating record |
| Where CTMS milestones and eTMF content are reconciled | Manually, during the war room | Rarely reconciled at all | Automatically, as milestones fire |
Cloudbyz's approach treats this as an architecture question rather than an overlay-dashboard question. Native CTMS↔eTMF on Salesforce means studies, countries, sites, milestones, monitoring activity, and essential records share one governed data model with a common security and audit spine. Inside that, the AI eTMF Agent works as an embedded capability rather than a separate tool: it auto-classifies incoming documents against the TMF Reference Model taxonomy, applies metadata for study, country, site, investigator, and milestone context, and runs QC checks to catch mis-filings, missing metadata, and mismatches between what CTMS says happened and what eTMF actually holds.
When a CTMS milestone site activation, a completed monitoring visit, a protocol amendment fires without its expected supporting records in eTMF, the agent can raise a targeted task to the right owner rather than leaving the gap buried in an aggregate completeness score.
When it detects the kind of pattern Section 4.2.3 is concerned with late changes to critical documents, repeated re-approvals, unusual access to blinding-sensitive records it can surface that as part of a planned, risk-based review stream instead of depending on someone remembering to pull an audit-trail export.
This same structure lines up with ALCOA+ expectations for data integrity attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, and available.
Each classification, metadata update, approval, and QC action is attributable and timestamped in a single audit trail, and because records are managed inside one validated platform rather than stitched together across file shares, a TMF narrative that used to require forensic reconstruction can be generated directly from system history instead.
For Regulatory Affairs leads, Clinical Operations Directors, and Quality heads, the shift this represents is that TMF readiness stops being a project scheduled before an inspection and becomes a property of how the trial runs day to day.
How much of the reactive clean-up time this actually removes depends on document volume, how consistently the agent's suggestions are reviewed, and how the CTMS-eTMF connection is configured but the direction is the same either way: readiness that's demonstrated continuously holds up better under Section 4.2.3 than readiness assembled once, right before someone asks for it.